mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0092 |
0.8 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
simvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.0095 |
0.8 |
mRNA |
pitstop2 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.009 |
0.8 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
-0.009 |
0.8 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.8 |
mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
-0.0078 |
0.8 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.9 |
mRNA |
BRD8958 |
CTRPv2 |
pan-cancer |
AAC |
-0.0073 |
0.9 |